Evidence-Based Medicine

Research Appraisals

Evidence-based critical appraisals of the latest medical research, systematically evaluated using Oxford CEBM methodology.

Showing 2 appraisals

otherEvidence: Moderate
95CEBM

Lifetime data analysis

Kolmogorov-Smirnov and Cramér-von Mises tests for the k-sample problem with left-truncated and right-censored data

k-Sample versions of the Kolmogorov-Smirnov and Cramér-von Mises tests are proposed for data subject to left truncation and right censoring. Their asymptotic behaviour is studied and a bootstrap resampling plan is proposed to approximate the null distribution of the new tests. The performance of the tests with finite sample sizes is investigated in a simulation study, where the classical log-rank test is also considered. An illustration with a real dataset regarding unemployment times is discussed.

18 May 2026

Read appraisal →
otherEvidence: Moderate
70CEBM

Lifetime data analysis

Q-learning via deep learning-based Buckley-James method for non-linear censored data

In healthcare, personalized treatment strategies are vital for improving patient outcomes, especially under right-censored survival data. We propose Dynamic Deep Buckley-James Q-Learning, a novel counterfactual Q-learning algorithm that integrates deep learning with the Buckley-James method to simultaneously address censoring and nonlinear modeling challenges. By explicitly capturing complex, nonlinear interactions between covariates and treatment effects, the algorithm robustly estimates optimal dynamic treatment regimes. Leveraging a counterfactual framework, we define and estimate potential survival outcomes under hypothetical treatment sequences, enabling unbiased Q-function estimation even in the presence of time-dependent covariates and right censoring. The algorithm maximizes the expected imputed survival reward under these counterfactual scenarios. Simulation studies and real-world data analysis demonstrate its superior performance in predictive accuracy and treatment decision-making, offering a powerful framework for individualized care in complex clinical settings.

6 Apr 2026

Read appraisal →